HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gilberto Schwartsmann Selected Research

Gastrin-Releasing Peptide

5/2017A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism.
9/2016Improvement in Symptoms of Autism Spectrum Disorder in Children With the Use of Gastrin-Releasing Peptide: An Open Trial.
5/2016Improvement of autism spectrum disorder symptoms in three children by using gastrin-releasing peptide.
7/2014Expression of gastrin-releasing peptide receptor in epidermoid carcinoma of the anal canal.
10/2012Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling.
1/2012The gastrin-releasing peptide receptor as a marker of dysplastic alterations in cervical epithelial cells.
9/2010Protective effect of gastrin-releasing peptide receptor antagonist in carrageenan-induced pleural inflammation in rats.
8/2010Effects of the gastrin-releasing peptide antagonist RC-3095 in a rat model of ulcerative colitis.
11/2009Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.
8/2009A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gilberto Schwartsmann Research Topics

Disease

44Neoplasms (Cancer)
06/2022 - 01/2002
14Glioma (Gliomas)
01/2017 - 08/2003
11Breast Neoplasms (Breast Cancer)
01/2020 - 05/2003
9Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2002
9Sepsis (Septicemia)
04/2017 - 10/2002
8Brain Neoplasms (Brain Tumor)
05/2019 - 01/2008
8Glioblastoma (Glioblastoma Multiforme)
05/2019 - 01/2008
6Medulloblastoma
01/2016 - 12/2009
5Prostatic Neoplasms (Prostate Cancer)
02/2021 - 12/2004
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 10/2014
5Colonic Neoplasms (Colon Cancer)
08/2012 - 01/2005
5Carcinoma (Carcinomatosis)
01/2012 - 09/2002
4Autistic Disorder (Autism)
05/2017 - 03/2012
3Neoplasm Metastasis (Metastasis)
01/2021 - 05/2011
3Fatigue
01/2020 - 01/2016
3Cognitive Dysfunction
11/2017 - 12/2009
3Autism Spectrum Disorder
05/2017 - 05/2016
3Inflammation (Inflammations)
01/2015 - 08/2010
3Gastritis
06/2013 - 08/2009
2Vomiting
01/2020 - 02/2016
2Melanoma (Melanoma, Malignant)
01/2019 - 12/2004
2Dihydropyrimidine Dehydrogenase Deficiency
06/2018 - 11/2016
2Adenocarcinoma
02/2016 - 01/2010
2Lung Neoplasms (Lung Cancer)
01/2016 - 01/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 10/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 10/2007
2Arthritis (Polyarthritis)
06/2013 - 01/2012
2Uveitis
06/2013 - 11/2009
2Ulcerative Colitis
08/2010 - 03/2010
2Lymphoma (Lymphomas)
06/2010 - 08/2003
2Neuroblastoma
08/2009 - 06/2009
2Mental Disorders (Mental Disorder)
07/2007 - 04/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2007 - 10/2002
2Disease Progression
10/2006 - 08/2003
1Diarrhea
06/2022
1Nausea
01/2020

Drug/Important Bio-Agent (IBA)

31Bombesin Receptors (Bombesin Receptor)IBA
01/2017 - 05/2004
18Gastrin-Releasing PeptideIBA
05/2017 - 02/2004
15Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
01/2015 - 01/2006
10Pharmaceutical PreparationsIBA
02/2021 - 10/2002
9BombesinIBA
07/2014 - 07/2003
7Irinotecan (Camptosar)FDA LinkGeneric
06/2022 - 01/2005
7Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 01/2010
7Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 08/2003
7Histone Deacetylase InhibitorsIBA
01/2016 - 08/2009
6ErbB Receptors (EGF Receptor)IBA
05/2019 - 01/2007
6Nerve Growth Factors (Neurotrophins)IBA
01/2019 - 01/2009
5NeuropeptidesIBA
01/2013 - 05/2004
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012 - 06/2007
4Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2005
4TamoxifenFDA LinkGeneric
11/2017 - 05/2003
4DNA (Deoxyribonucleic Acid)IBA
04/2017 - 10/2002
4ParaffinIBA
07/2014 - 01/2007
4Peptides (Polypeptides)IBA
06/2007 - 07/2003
3Messenger RNA (mRNA)IBA
05/2019 - 05/2008
3Nerve Growth Factor (NGF)IBA
01/2019 - 01/2009
3Phosphotransferases (Kinase)IBA
01/2019 - 01/2013
3GemcitabineFDA Link
12/2018 - 10/2007
3Antineoplastic Agents (Antineoplastics)IBA
02/2018 - 08/2003
3LigandsIBA
04/2017 - 03/2010
3CytokinesIBA
10/2012 - 01/2006
3trkB ReceptorIBA
08/2012 - 01/2010
3EnzymesIBA
04/2010 - 08/2003
2Cytochrome P-450 CYP3AIBA
06/2022 - 12/2015
2abirateroneIBA
02/2021 - 11/2020
2ChromatinIBA
05/2019 - 12/2013
2TropomyosinIBA
01/2019 - 01/2013
2Leucovorin (Folinic Acid)FDA Link
12/2018 - 02/2016
2UracilIBA
06/2018 - 11/2016
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
06/2018 - 11/2016
2dihydrouracilIBA
06/2018 - 11/2016
2AntigensIBA
04/2017 - 06/2008
2Therapeutic UsesIBA
05/2016 - 07/2014
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
12/2015 - 08/2014
2Butyric Acid (Butanoic Acid)IBA
12/2013 - 06/2011
2Proteins (Proteins, Gene)FDA Link
01/2012 - 05/2008
2Omeprazole (Prilosec)FDA LinkGeneric
03/2011 - 08/2009
2Indomethacin (Indometacin)FDA LinkGeneric
03/2011 - 08/2009
2Adenosine Triphosphate (ATP)IBA
03/2011 - 08/2003
2Acetylcysteine (Siran)FDA LinkGeneric
03/2011 - 04/2010
2HLA Antigens (Human Leukocyte Antigens)IBA
08/2010 - 03/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 06/2010
2KIR ReceptorsIBA
08/2010 - 03/2010
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
03/2010 - 07/2007
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
03/2010 - 05/2009
2Phosphatidylinositols (Phosphatidylinositol)IBA
06/2009 - 05/2008
2Temozolomide (Temodar)FDA LinkGeneric
06/2009 - 09/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008 - 12/2004
2Cisplatin (Platino)FDA LinkGeneric
10/2007 - 10/2002
2Thalidomide (Thalomid)FDA Link
12/2004 - 08/2003
2NucleotidesIBA
09/2003 - 08/2003
2NucleosidesIBA
09/2003 - 08/2003
1Keratin-20 (Cytokeratin 20)IBA
01/2021
1Abiraterone AcetateIBA
11/2020

Therapy/Procedure

21Therapeutics
01/2021 - 10/2002
9Drug Therapy (Chemotherapy)
01/2020 - 01/2003
4Radiotherapy
06/2009 - 01/2003
2Chemoradiotherapy
08/2012 - 11/2009
2Ligation
04/2010 - 01/2006
1Metastasectomy
01/2021